HALO vs LCID · P/E 15, rev $857.7M vs rev $687.8M
Halozyme Therapeutics Inc (HALO) versus Lucid Group Inc (LCID) — a side-by-side from cached financials, not a winner call.
Halozyme Therapeutics Inc (HALO) is a biotechnology company listed on US.
Lucid Group Inc (LCID) is a auto manufacturers company listed on NASDAQ. It is led by Silvio Napoli.
Latest reported HALO revenue for 2026-06-30 was $857.7M. Net income was $380.0M. HALO currently screens at market cap $7.10B and trailing P/E 15.3.
Latest reported LCID revenue for 2026-06-30 was $687.8M. Net income was -$2.06B. LCID currently screens at market cap $2.04B.
HALO currently screens at market cap $7.10B and trailing P/E 15.3. LCID currently screens at market cap $2.04B.
Not investment advice. Open the HALO and LCID stock pages for the full models.
Not investment advice.